Fenugreek (Trigonella foenum-graecum)

This herb is approved to treat inflammatory cutaneous diseases. It acts as soothing emollient via its major active compounds mucilages including mannogalactans which account for 25-45% of the extract. Proteins comprise another 25-30% of the extract, while steroid saponins including trigofoenosides and foenugracein account for about 15%. Trigonelline, sterols, volatile oils, and flavonoids such as orientin and vitexin are the other active compounds. Topical sensitization is rare. Fenugreek must not be administered during pregnancy (3).

Updated: July 21, 2015 — 1:57 pm